Procena pokazatelja kvaliteta medicinske nege za farmakoterapiju kod pacijenata sa ishemijskim moždanim udarom: bolnička studija

  • Oksana Levytska Danylo Halytsky Lviv National Medical University, Department of Organization and Economics of Pharmacy
  • Bohdan Hromovyk Danylo Halytsky Lviv National Medical University, Department of Organization and Economics of Pharmacy
  • Tetiana Ryvak Danylo Halytsky Lviv National Medical University, Department of Clinical Pharmacy, Pharmacotherapy and Medical Standardization
  • Kateryna Kostyana Danylo Halytsky Lviv National Medical University, Department of Clinical Pharmacy, Pharmacotherapy and Medical Standardization
DOI: https://doi.org/10.5937/arch%20of%20pharm70-26191
Ključne reči: ishemijski moždani udar, kvalitet medicinske nege, lekovi, farmakoterapija, klinički indikator kvaliteta

Sažetak


Ishemijski moždani udar spada u vodeće uzroke smrti i invaliditeta u svetu i Ukrajini. Stope preživljavanja zavise od kvaliteta pružene medicinske nege.

Istraživanje je imalo za cilj da analizira kvalitet medicinske nege u vezi sa farmakoterapijom ishemijskog moždanog udara. Klinički pokazatelji kvaliteta su kvantitativni ili kvalitativni dokazi ili konsenzus sa direktnim uticajem na ishod.

Šest se odnosi na farmakoterapiju akutnog  ishemijskog moždanog udara (trombolitička, antiagregaciona, antikoagulantna i terapija za snižavanje lipida propisana u različitim fazama boravka u bolnici) koja je ispitana u ovoj retrospektivnoj analizi 151 pacijenata jedne od specijalizovanih bolnica u gradu Lviv.

Klinički pokazatelji kvaliteta medicinske nege pokazali su da je farmakološki tretman primenom antitrombotika (antiagregacionih lekova i antikoagulanasa) pri prijemu u bolnicu odgovarao standardima, a kvalitet je definisan kao visok sa stopama od 65,6% i 85,4% (od ukupnog broja pacijenata). Nakon otpusta, analiza farmakoterapije otkrila je probleme sa antitrombotskom (2 indikatora) i farmakoterapijom za snižavanje lipida (1indikator) sa stopama od 33,3% i 47,7%. Rezultati su pokazali  postojanje problema povezanih sa farmakoterapijom. Za poboljšanje kvaliteta medicinske nege predložene su korektivne mere   od tri algoritma.

Reference

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics – 2019. Update: A Report from the American Heart Association. Circulation. 2019;139:e56-e528. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000659.

Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018;38(2):208-11. doi: 10.1055/s-0038-1649503.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al. American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. Available from: https://www.ahajournals.org/doi/10.1161/STR.0000000000000158.

Freeman WD, Dawson SB, Raper C, Thiemann K, Josephson SA, Barrett KM. Neurohospitalists reduce length of stay for patients with ischemic stroke. Neurohospitalist. 2011;1(2):67-70. doi:10.1177/1941875210394202.

Basheti IA, Ayasrah SM, Ahmad M. Identifying treatment related problems and associated factors among hospitalized post-stroke patients through medication management review: A multi-center study. Saudi Pharm J. 2019;27(2), 208-19. doi: 10.1016/j.jsps.2018.10.005.

Di Simone E, Giannetta N, Auddino F, Cicotto A, Grilli D, Di Muzio M. Medication errors in the emergency department: Knowledge, attitude, behavior, and training needs of nurses. Indian J Crit Care Med. 2018;22:346-52. doi: 10.4103/ijccm.IJCCM_63_18.

Jellinek-Cohen SP, Li M, Husk G. Enoxaparin dosing errors in the emergency department. World J Emerg Med. 2018;9(3):195-202. doi: 10.5847/wjem.j.1920-8642.2018.03.006.

Michaels AD, Spinler SA, Leeper BE, Ohman M, Alexander K P, Newby KL et al. Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association. Circulation, 2010;121:1664-82. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0b013e3181d4b43e.

Ormseth CH, Sheth KN, Saver JL, Fonarow GC, Schwamm LH. The American Heart Association’s Get with the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke and Vascular Neurology, 2017; 2:e000092. doi: 10.1136/svn-2017-000092. Available from: https://svn.bmj.com/content/2/2/94.

Turner GM, Calvert M, Feltham MG, Ryan R, Finnikin S, Marshall T. Clinical and Demographic Characteristics Associated With Suboptimal Primary Stroke and Transient Ischemic Attack Prevention: Retrospective Analysis. Stroke. 2018;49(3):682-7. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.117.020080.

Ung D, Kim J, Thrift AG, Cadilhac DA, Andrew NE, Sundararajan V et al. Promising Use of Big Data to Increase the Efficiency and Comprehensiveness of Stroke Outcomes Research. Stroke. 2019;50:1302-9. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.020372.

The Ljubljana Charter on Reforming Health Care. BMJ. 1996;312(7047):1664-5. Available from: http://www.euro.who.int/en/publications/policy-documents/the-ljubljana-charter-on-reforming-health-care,-1996.

Vuori HV. Quality assurance of health services: concepts and methodology: Copenhagen: Regional Office for Europe. World Health Organization; Albany, N.Y.: WHO Publications Centre: 1982. 127 p. Available from: https://trove.nla.gov.au/version/26291550.

Emmett E, Stevens E, Wang Y, McKevitt C, Wolfe C DA. The Burden of Stroke in Europe Report. King's College London for the Stroke Alliance for Europe (SAFE): 2017. Available from: https://www.stroke.org.uk/sites/default/files/the_burden_of_stroke_in_europe_-_challenges_for_policy_makers.pdf.

Ischemic stroke (emergency, primary, secondary (specialized) medical care, medical rehabilitation). Unified clinical protocol of medical care. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 5]. Available from: https://zakon.rada.gov.ua/rada/show/v0602282-12#n2.

Rehabilitation, prevention and treatment complications and discharge planning for ischemic stroke. Adapted clinical guideline based on evidence. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 10]. Available from: http://mtd.dec.gov.ua/images/dodatki/2012_602/2012_602dod5AKN.pdf.

Recommendations for the management of patients with ischemic stroke and transient ischemic attack. Adapted clinical guideline based on evidence. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 8]. Available from: https://zakon.rada.gov.ua/rada/show/va602282-12#n4.

Modern principles of diagnosis and treatment of patients with acute ischemic stroke and transient ischemic attack. Adapted clinical guideline based on evidence. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 15]. Available from: https://dec.gov.ua/wp-content/uploads/2019/11/2012_602dod1akn.pdf.

Systemic thrombolysis in ischemic stroke (emergency, secondary (specialized) medical care. Unified clinical protocol of medical care. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 24]. Available at: https://zakon.rada.gov.ua/rada/show/vb602282-12#n3.

Donabedian A. The Quality of care: how can it be assessed? JAMA, 1988;12:1743-8. doi: 10.1001/jama.260.12.1743.

Mainz J. Defining and classifying clinical indicators for quality improvement: Int J Qual Health Care. 2003;15(6):523-530. Available from: https://doi.org/10.1093/intqhc/mzg081.

Measuring and improving quality of care: A report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke, 2000;31(4):1002-12. doi: 10.1161/01.cir.101.12.1483.

Reeves MJ, Parker C, Fonarow GC, Smith EE, Schwamm LH. Development of stroke performance measures: definitions, methods, and current measures. Stroke. 2010;41(7):1573-80. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.109.577171.

Peacock J, Peacock P. Oxford Handbook of Medical Statistics. Oxford University Press: 2011. 544 p.

Cooray C, Mazya M, Mikulik R, Jurak L, Brozman M, Ringleb P et al. Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke Onset. Stroke, 2019;50:1149-55. doi: 10.1161/STROKEAHA.118.024575.

Gorodnycha O, Zimenkovsky A, Kostyana K. Drug-related problems associated with use of statins in Ukraine: a hospital-based study. Pharmacia. 2016;63(4):29-34.

Wittich CM, Burkle CM, Lanier WL. Medication errors: an overview for clinicians. Mayo Clin Proc. 2014;89(8):1116-25. Available from: https://doi.org/10.1016/j.mayocp.2014.05.007.

Lindsay PM, Kapral MK, Holloway R, Gladstone DJ, Tu JV, Laupacis A, Grimshaw JM. Canadian Stroke Quality of Care Study: Identification of performance indicators for acute stroke care. CMAJ. 2005;172(3):363-5. doi: 10.1503/cmaj.045310.

Levytska OR, Hromovyk BP, Unhurian LM, Kostyana KV. Clinical-epidemiological and pharmacoepidemiological investigation of acute cerebrovascular accidents. Journal of Applied Pharmaceutical Science. 2017;7(07):168-75. doi: 10.7324/JAPS.2017.70725.

Objavljeno
2020/07/02
Broj časopisa
Vol. 70 Br. Notebook 3 (2020): Arhiv za farmaciju
Rubrika
Stručni rad
Autori koji objavljuju u ovom časopisu pristaju na sledeće uslove:

  1. Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.

  2. Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.

  3. Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).